BOVAS: Bifurcation Optimal Viewing Angle Selection Study
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by University Hospital, Gasthuisberg.
Recruitment status was Not yet recruiting
Katholieke Universiteit Leuven
Information provided by:
University Hospital, Gasthuisberg
First received: February 18, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
An optimal angiographic viewing angle is critical for correct diagnosis and intervention in coronary bifurcation lesion percutaneous coronary interventions (PCI). The current study aims at validating a dedicated software tool (MEDIS, Leiden, The Netherlands) that will improve the selection of the best viewing angle.
Coronary Bifurcation Lesion
||Observational Model: Case-Only
Time Perspective: Prospective
||Bifurcation Optimal Viewing Angle Selection Study
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||December 2011 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
In patients undergoing coronary angiography, those with an angiographically significant bifurcation lesion will be identified. A total of 50 patients will be selected. After diagnostic angiography, optimal viewing angles for the bifurcation lesion will be calculated using the dedicated Medis (Leiden, the Netherlands) software.
- Patient older than 18 years of age
- Informed consent available
- Hemodynamic unstability (cardiogenic shock, life-threatening arrhythmias, inotropic support)
- Impaired renal function (serum creatinine > 2.0 mg/dl)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||dr. Tom Adriaenssens, University Hospitals Leuven
History of Changes
|Other Study ID Numbers:
||BOVAS 2 08.02.2011
|Study First Received:
||February 18, 2011
||February 18, 2011
||Belgium: Ethics Committee
Keywords provided by University Hospital, Gasthuisberg:
ClinicalTrials.gov processed this record on August 28, 2014
optimal viewing angle